Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Cash from Financing Activities (2024 - 2025)

Historic Cash from Financing Activities for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $705.5 million.

  • Abivax's Cash from Financing Activities rose 1031441.3% to $705.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $681.1 million, marking a year-over-year change of. This contributed to the annual value of $30.1 million for FY2024, which is 9168.93% down from last year.
  • Abivax's Cash from Financing Activities amounted to $705.5 million in Q3 2025, which was up 1031441.3% from -$9.9 million recorded in Q2 2025.
  • Abivax's 5-year Cash from Financing Activities high stood at $705.5 million for Q3 2025, and its period low was -$9.9 million during Q2 2025.